Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Management of Pyrexia of Unknown Origin

Initial Diagnostic Approach

  • The American College of Radiology recommends obtaining comprehensive blood cultures before initiating any antimicrobial therapy to maximize diagnostic yield 1
  • A complete blood count with differential should be performed to assess for neutropenia and monitor trends 1
  • Neutropenia severity should be classified: Mild (ANC 1.0-1.5 × 10⁹/L), Moderate (ANC 0.5-1.0 × 10⁹/L), Severe (ANC <0.5 × 10⁹/L) 1, 2
  • Chest imaging (X-ray or CT) should be ordered for patients with respiratory symptoms or persistent fever 1

Risk-Stratified Treatment

  • The American College of Cardiology is not applicable here, however, severe neutropenia (ANC <0.5 × 10⁹/L) with fever constitutes a medical emergency requiring same-day broad-spectrum antibacterial therapy 1, 3
  • Broad-spectrum antibiotics should be initiated immediately without waiting for culture results in high-risk patients 1, 2
  • Consider antibacterial prophylaxis with levofloxacin or ciprofloxacin 500 mg daily for severe neutropenia 2
  • Hemodynamically unstable patients should be monitored every 2-4 hours with urgent infectious disease consultation 3

Advanced Diagnostic Strategies

  • FDG-PET/CT should be considered for patients with prolonged unexplained fever, particularly in immunosuppressed patients, as it demonstrates high sensitivity and specificity for detecting infections and inflammatory processes 1
  • The Journal of the American College of Radiology reports that FDG-PET/CT had "high" clinical impact in 79% of cases, prompting specialist referrals or changes to antimicrobial therapy 4
  • FDG-PET/CT correctly identified fever source in 88% of immunosuppressed children with pyrexia of unknown origin 4

Special Populations

  • For returned travelers with pyrexia of unknown origin, up to three daily blood films should be obtained to exclude malaria 5
  • Assess for viral hemorrhagic fever risk and implement appropriate isolation precautions 5
  • Consider cephalosporins or fluoroquinolones for fever with significant diarrhea suggesting invasive bacterial disease 5
  • Use tinidazole or metronidazole for suspected amoebic dysentery 5
  • For children with pyrexia of unknown origin, consider bacterial pneumonia when fever >38.5°C with chest recession and respiratory rate >50/min in children under 3 years 6
  • Obtain chest radiograph in young children with pyrexia of unknown origin and no alternative source, as 25% may show pneumonia 6

REFERENCES

1

Management of Pyrexia of Unknown Origin [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Neutrophilia and Lymphocytopenia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Assessment for Severe Neutropenia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025